Shree Ganesh Bio-Tech (India) Limited Schedules Board Meeting on May 14, 2026 to Approve FY26 Audited Financial Results

1 min read     Updated on 04 May 2026, 11:33 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Shree Ganesh Bio-Tech (India) Limited has informed stock exchanges of a board meeting to be held on May 14, 2026, under Regulation 29 of SEBI (LODR) Regulations, 2015. The meeting's primary agenda is to approve the audited standalone financial results for the quarter and year ended March 31, 2026, along with auditor reports. The intimation was filed with BSE Limited, The Calcutta Stock Exchange Ltd, and Metropolitan Stock Exchange of India Limited, and was signed by Director Aman Patel on May 4, 2026.

powered bylight_fuzz_icon
39463383

*this image is generated using AI for illustrative purposes only.

Shree Ganesh Bio-Tech (India) Limited has notified the stock exchanges of an upcoming board meeting scheduled for Thursday, May 14, 2026, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, dated May 4, 2026, was submitted to BSE Limited, The Calcutta Stock Exchange Ltd, and Metropolitan Stock Exchange of India Limited.

Board Meeting Agenda

The board meeting has been convened to transact the following key business:

Agenda Item: Details
Financial Results: Approve and take on record the Audited Standalone Financial Results for the quarter and year ended March 31, 2026
Auditor Reports: Consider reports of the Auditors on the standalone financial results
Other Business: Any other matter with the permission of the board as deemed fit

Regulatory Compliance

The intimation has been filed in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates listed companies to notify stock exchanges in advance of board meetings where financial results are to be considered. The notice was duly signed by Aman Patel, Director of Shree Ganesh Bio-Tech (India) Limited.

Exchange Notifications

The company submitted the board meeting intimation to the following exchanges:

  • BSE Limited, P J Tower, Dalal Street, Mumbai
  • The Calcutta Stock Exchange Ltd, Kolkata
  • Metropolitan Stock Exchange of India Limited, Mumbai

The filing was made on May 4, 2026, ahead of the scheduled board meeting date of May 14, 2026.

Historical Stock Returns for Shree Ganesh Bio-Tech

1 Day5 Days1 Month6 Months1 Year5 Years
-3.17%0.0%+1.67%-16.44%-34.41%-89.85%

How might Shree Ganesh Bio-Tech's FY2026 annual financial results compare to the previous year in terms of revenue growth and profitability margins?

Could the board meeting on May 14, 2026 potentially include announcements beyond financial results, such as dividend declarations or strategic expansions in the biotech sector?

How has Shree Ganesh Bio-Tech's stock performance on BSE trended leading up to this results announcement, and what are analyst expectations for the company?

like17
dislike

Shree Ganesh Bio-Tech Submits Q4FY26 SEBI Compliance Certificate for Share Dematerialization

1 min read     Updated on 07 Apr 2026, 02:08 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Shree Ganesh Bio-Tech (India) Limited submitted its Q4FY26 compliance certificate under SEBI Regulation 74(5) for share dematerialization activities. The certificate, issued by Satellite Corporate Services Private Limited on 06.04.2026, confirms no physical share certificates were received for dematerialization during the quarter ended 31st March 2026, fulfilling mandatory regulatory requirements.

powered bylight_fuzz_icon
37053509

*this image is generated using AI for illustrative purposes only.

Shree ganesh bio-tech (India) Limited has filed its quarterly compliance certificate with stock exchanges, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The submission, dated 06.04.2026, covers the quarter ended 31st March 2026.

Regulatory Compliance Filing

The company submitted the mandatory certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 to multiple stock exchanges including BSE Limited, The Calcutta Stock Exchange Ltd, and Metropolitan Stock Exchange of India Limited.

Parameter: Details
Filing Date: 06.04.2026
Quarter Covered: Q4FY26 (ended 31st March 2026)
Regulation: SEBI Regulation 74(5)
Registrar Agent: Satellite Corporate Services Private Limited

Certificate Details and Confirmation

Satellite Corporate Services Private Limited, serving as the company's Registrar & Share Transfer Agent, issued the compliance certificate. The certificate confirms adherence to standard regulatory requirements for dematerialization processes.

The key confirmations in the certificate include:

  • Securities comprised in certificates have been listed on stock exchanges
  • Certificates after due verification have been mutilated and cancelled
  • Depository name has been substituted in records as registered owner

Dematerialization Activity Status

For the quarter ended 31st March 2026, the certificate specifically states that no physical share certificates were received for dematerialization. This indicates minimal physical-to-electronic share conversion activity during Q4FY26.

Metric: Q4FY26 Status
Physical Certificates Received: None
Dematerialization Activity: No activity
Compliance Status: Completed

Stock Exchange Communications

The filing was submitted to three stock exchanges where the company maintains listings, ensuring comprehensive regulatory compliance across all trading platforms. The company's registered office is located in Kolkata, with corporate identification number L70101WB1982PLC121196.

This quarterly submission represents standard regulatory practice, demonstrating the company's commitment to maintaining transparency in share transfer and dematerialization processes as required by SEBI regulations.

Historical Stock Returns for Shree Ganesh Bio-Tech

1 Day5 Days1 Month6 Months1 Year5 Years
-3.17%0.0%+1.67%-16.44%-34.41%-89.85%

What factors might be contributing to the absence of dematerialization activity, and could this indicate changes in investor behavior or share trading patterns?

How might Shree Ganesh Bio-tech's business performance in FY26 compare to previous years, given the regulatory filing timeline?

Will the company's listing across multiple exchanges including smaller ones like Calcutta Stock Exchange provide any strategic advantages for future capital raising?

like15
dislike

More News on Shree Ganesh Bio-Tech

1 Year Returns:-34.41%